JavaScript seems to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.

Human Tissue-type Plasminogen Activator (tPA) AssayMax™ELISA Kit

Human Tissue-type Plasminogen Activator (tPA) AssayMax™ELISA Kit

Move your mouse over image or click to enlarge

Human Tissue-type Plasminogen Activator (tPA) AssayMax™ELISA Kit

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.

View Datasheet

Cat#	Size	Price	Qty	Buy
ET1001-1	96 Well Plate	£260.00

Additional Information

Property	Value or Rating
Manufacturer	Assaypro, LLC.
Product Type	AssayMax™ ELISA Kits
Samples	Serum, Urine, Saliva, Milk, Cell Culture, Tissue Extract
Species	Human
Reactivity	Human
Assay Format	Sandwich ELISA
Product Size	96 Well Plate
Range	0.0156-1 ng/ml
Plex Number	1
Storage	Refer to component labels for details
Entrez Gene	5327
Omim	173370
UniProt	P00750
UniGene	Hs.491582
Special Notes	For Research Use Only, Not To Be Used For Diagnostic Purposes
References	* Mataga N et al. (2004) Experience-Dependent Pruning of Dendritic Spines in Visual Cortex by Tissue Plasminogen Activator. Neuron 44:1031-1041 * Sheikh AM et al. (2005) Lysophosphatidylcholine induces tPA gene expression through CRE-dependent mechanism. Biochemical and Biophysical Research Communications 329(1):71-77 * Nagai T et al. (2006) The rewards of nicotine: regulation by tissue plasminogen activator-plasmin system through protease activated receptor-1. The Journal of Neuroscience 26(47):12374-12383 * Roth GA et al. (2006) Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells. Journal of Thrombosis and Haemostasis 4(10):2256-2261 * Katsutani M et al. (2007) Glucose-Based PD Solution, But Not Icodextrin-Based PD Solution, Induces Plasminogen Activator Inhibitor-1 and Tissue-Type Plasminogen Activator in Human Peritoneal Mesothelial Cells via ERK1/2. Therapeutic Apheresis and Dialysis 11(2): 94-100 * Demirel A et al. (2008) Is Familial Mediterranean Fever a thrombotic disease or not? Eur J Pediatr. 167(3):279-285 * He WJ et al. (2008) Activated protein C ratio, plasma tissue factor activity and activated factor VII in Chinese patients with coronary heart disease. Eur J Med Res. 13:47-51 * Markosyan N and Duffy DM (2009) Prostaglandin E2 acts via multiple receptors to regulate plasminogen-dependent proteolysis in the primate periovulatory follicle. Endocrinology. 150(1):435-44 * Tabak O et al. (2009) Hypertension and hemostatic/fibrinolytic balance disorders. Clin Invest Med 32:E285 * Kesavan K et al. (2010) Annexin A2 Is a Molecular Target for TM601, a Peptide with Tumor-targeting and Anti-angiogenic Effects. J Biol Chem. 285(7):4366-4374 * Munuswamy-Ramanujam G et al. (2010) Neuroserpin, a thrombolytic serine protease inhibitor (serpin), blocks transplant vasculopathy with associated modification of T-helper cell subsets. Thromb Haemost. 103(3):545-555 * Suzuki N et al. (2010) GnRH receptor and peritoneal plasmin activity. Gynecol Endocrinol. 26(9):669-672 * Turfaner N et al. (2010) Ezetimibe Therapy and Its Influence on Oxidative Stress and Fibrinolytic Activity. South Med J. 103:428-433 * Zhu H et al. (2012) Activation of coagulation, anti-coagulation, fibrinolysis and the complement system in patients with urticaria. Asian Pac J Allergy Immunol 31:43-50 * Baumer W et al. (2013) Pharmacokinetics and thrombolytic effects of the recombinant tissue-type plasminogen activator in horses. BMC Veterinary Research 9:158 * Ekwere T et al. (2013) Assessment of some plasma fibrinolytic proteins in sickle cell anemia patients in steady state and in vaso-occlusive crises. Journal of Applied Hematology. 4(4):131-136 * Siennicka A et al. (2013) Haemostatic factors and intraluminal thrombus thickness in abdominal aortic aneurysm. Is secondary fibrinolysis relevant? J Physiol Pharmacol. 64(3):321-30 * Vieira ML et al. (2013) Interaction of Leptospira interrogans with Human Proteolytic Systems Enhances Dissemination through Endothelial Cells and Protease Levels. Infect Immun. 81(5):1764-74. doi: 10.1128/IAI.00020-13. Epub 2013 Mar 11 * Akkok B et al. (2014) Pleural effusion and plasma levels of fibrinolytic parameters in tuberculosis pleurisy and contribution to the diagnosis. Eurasian J Pulmonol. 16: 84-88 * Topcuoglu A et al. (2014) Effects of hormone replacement therapy on plasma and tissue fibrinolytic activity in a rat model of surgically induced menopause. Clin Invest Med. 2014 Apr 1;37(2):E85-92 * Halim SA et al. (2015) Simultaneous Consideration of Multiple Candidate Protein Biomarkers for Long-Term Risk for Cardiovascular Events. Circ Cardiovasc Genet. 8(1):168-77 * Rhone P (2018) Comprehensive analysis of haemostatic profile depending on clinicopathological determinants in breast cancer patients. Biosci Rep. 29;38(2) * Siennicka A et al. (2018) Tissue factor levels and the fibrinolytic system in thin and thick intraluminal thrombus and underlying walls of abdominal aortic aneurysms. Journal of Vascular Surgery. " title=" * Mataga N et al. (2004) Experience-Dependent Pruning of Dendritic Spines in Visual Cortex by Tissue Plasminogen Activator. Neuron 44:1031-1041 * Sheikh AM et al. (2005) Lysophosphatidylcholine induces tPA gene expression through CRE-dependent mechanism. Biochemical and Biophysical Research Communications 329(1):71-77 * Nagai T et al. (2006) The rewards of nicotine: regulation by tissue plasminogen activator-plasmin system through protease activated receptor-1. The Journal of Neuroscience 26(47):12374-12383 * Roth GA et al. (2006) Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells. Journal of Thrombosis and Haemostasis 4(10):2256-2261 * Katsutani M et al. (2007) Glucose-Based PD Solution, But Not Icodextrin-Based PD Solution, Induces Plasminogen Activator Inhibitor-1 and Tissue-Type Plasminogen Activator in Human Peritoneal Mesothelial Cells via ERK1/2. Therapeutic Apheresis and Dialysis 11(2): 94-100 * Demirel A et al. (2008) Is Familial Mediterranean Fever a thrombotic disease or not? Eur J Pediatr. 167(3):279-285 * He WJ et al. (2008) Activated protein C ratio, plasma tissue factor activity and activated factor VII in Chinese patients with coronary heart disease. Eur J Med Res. 13:47-51 * Markosyan N and Duffy DM (2009) Prostaglandin E2 acts via multiple receptors to regulate plasminogen-dependent proteolysis in the primate periovulatory follicle. Endocrinology. 150(1):435-44 * Tabak O et al. (2009) Hypertension and hemostatic/fibrinolytic balance disorders. Clin Invest Med 32:E285 * Kesavan K et al. (2010) Annexin A2 Is a Molecular Target for TM601, a Peptide with Tumor-targeting and Anti-angiogenic Effects. J Biol Chem. 285(7):4366-4374 * Munuswamy-Ramanujam G et al. (2010) Neuroserpin, a thrombolytic serine protease inhibitor (serpin), blocks transplant vasculopathy with associated modification of T-helper cell subsets. Thromb Haemost. 103(3):545-555 * Suzuki N et al. (2010) GnRH receptor and peritoneal plasmin activity. Gynecol Endocrinol. 26(9):669-672 * Turfaner N et al. (2010) Ezetimibe Therapy and Its Influence on Oxidative Stress and Fibrinolytic Activity. South Med J. 103:428-433 * Zhu H et al. (2012) Activation of coagulation, anti-coagulation, fibrinolysis and the complement system in patients with urticaria. Asian Pac J Allergy Immunol 31:43-50 * Baumer W et al. (2013) Pharmacokinetics and thrombolytic effects of the recombinant tissue-type plasminogen activator in horses. BMC Veterinary Research 9:158 * Ekwere T et al. (2013) Assessment of some plasma fibrinolytic proteins in sickle cell anemia patients in steady state and in vaso-occlusive crises. Journal of Applied Hematology. 4(4):131-136 * Siennicka A et al. (2013) Haemostatic factors and intraluminal thrombus thickness in abdominal aortic aneurysm. Is secondary fibrinolysis relevant? J Physiol Pharmacol. 64(3):321-30 * Vieira ML et al. (2013) Interaction of Leptospira interrogans with Human Proteolytic Systems Enhances Dissemination through Endothelial Cells and Protease Levels. Infect Immun. 81(5):1764-74. doi: 10.1128/IAI.00020-13. Epub 2013 Mar 11 * Akkok B et al. (2014) Pleural effusion and plasma levels of fibrinolytic parameters in tuberculosis pleurisy and contribution to the diagnosis. Eurasian J Pulmonol. 16: 84-88 * Topcuoglu A et al. (2014) Effects of hormone replacement therapy on plasma and tissue fibrinolytic activity in a rat model of surgically induced menopause. Clin Invest Med. 2014 Apr 1;37(2):E85-92 * Halim SA et al. (2015) Simultaneous Consideration of Multiple Candidate Protein Biomarkers for Long-Term Risk for Cardiovascular Events. Circ Cardiovasc Genet. 8(1):168-77 * Rhone P (2018) Comprehensive analysis of haemostatic profile depending on clinicopathological determinants in breast cancer patients. Biosci Rep. 29;38(2) * Siennicka A et al. (2018) Tissue factor levels and the fibrinolytic system in thin and thick intraluminal thrombus and underlying walls of abdominal aortic aneurysms. Journal of Vascular Surgery. " target="_blank"> * Mataga N et al. (2004) Experience-Dependent Pruning of Dendritic Spines in Visual Cortex by Tissue Plasminogen Activator. Neuron 44:1031-1041 * Sheikh AM et al. (2005) Lysophosphatidylcholine induces tPA gene expression through CRE-dependent mechanism. Biochemical and Biophysical Research Communications 329(1):71-77 * Nagai T et al. (2006) The rewards of nicotine: regulation by tissue plasminogen activator-plasmin system through protease activated receptor-1. The Journal of Neuroscience 26(47):12374-12383 * Roth GA et al. (2006) Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells. Journal of Thrombosis and Haemostasis 4(10):2256-2261 * Katsutani M et al. (2007) Glucose-Based PD Solution, But Not Icodextrin-Based PD Solution, Induces Plasminogen Activator Inhibitor-1 and Tissue-Type Plasminogen Activator in Human Peritoneal Mesothelial Cells via ERK1/2. Therapeutic Apheresis and Dialysis 11(2): 94-100 * Demirel A et al. (2008) Is Familial Mediterranean Fever a thrombotic disease or not? Eur J Pediatr. 167(3):279-285 * He WJ et al. (2008) Activated protein C ratio, plasma tissue factor activity and activated factor VII in Chinese patients with coronary heart disease. Eur J Med Res. 13:47-51 * Markosyan N and Duffy DM (2009) Prostaglandin E2 acts via multiple receptors to regulate plasminogen-dependent proteolysis in the primate periovulatory follicle. Endocrinology. 150(1):435-44 * Tabak O et al. (2009) Hypertension and hemostatic/fibrinolytic balance disorders. Clin Invest Med 32:E285 * Kesavan K et al. (2010) Annexin A2 Is a Molecular Target for TM601, a Peptide with Tumor-targeting and Anti-angiogenic Effects. J Biol Chem. 285(7):4366-4374 * Munuswamy-Ramanujam G et al. (2010) Neuroserpin, a thrombolytic serine protease inhibitor (serpin), blocks transplant vasculopathy with associated modification of T-helper cell subsets. Thromb Haemost. 103(3):545-555 * Suzuki N et al. (2010) GnRH receptor and peritoneal plasmin activity. Gynecol Endocrinol. 26(9):669-672 * Turfaner N et al. (2010) Ezetimibe Therapy and Its Influence on Oxidative Stress and Fibrinolytic Activity. South Med J. 103:428-433 * Zhu H et al. (2012) Activation of coagulation, anti-coagulation, fibrinolysis and the complement system in patients with urticaria. Asian Pac J Allergy Immunol 31:43-50 * Baumer W et al. (2013) Pharmacokinetics and thrombolytic effects of the recombinant tissue-type plasminogen activator in horses. BMC Veterinary Research 9:158 * Ekwere T et al. (2013) Assessment of some plasma fibrinolytic proteins in sickle cell anemia patients in steady state and in vaso-occlusive crises. Journal of Applied Hematology. 4(4):131-136 * Siennicka A et al. (2013) Haemostatic factors and intraluminal thrombus thickness in abdominal aortic aneurysm. Is secondary fibrinolysis relevant? J Physiol Pharmacol. 64(3):321-30 * Vieira ML et al. (2013) Interaction of Leptospira interrogans with Human Proteolytic Systems Enhances Dissemination through Endothelial Cells and Protease Levels. Infect Immun. 81(5):1764-74. doi: 10.1128/IAI.00020-13. Epub 2013 Mar 11 * Akkok B et al. (2014) Pleural effusion and plasma levels of fibrinolytic parameters in tuberculosis pleurisy and contribution to the diagnosis. Eurasian J Pulmonol. 16: 84-88 * Topcuoglu A et al. (2014) Effects of hormone replacement therapy on plasma and tissue fibrinolytic activity in a rat model of surgically induced menopause. Clin Invest Med. 2014 Apr 1;37(2):E85-92 * Halim SA et al. (2015) Simultaneous Consideration of Multiple Candidate Protein Biomarkers for Long-Term Risk for Cardiovascular Events. Circ Cardiovasc Genet. 8(1):168-77 * Rhone P (2018) Comprehensive analysis of haemostatic profile depending on clinicopathological determinants in breast cancer patients. Biosci Rep. 29;38(2) * Siennicka A et al. (2018) Tissue factor levels and the fibrinolytic system in thin and thick intraluminal thrombus and underlying walls of abdominal aortic aneurysms. Journal of Vascular Surgery.

Related Documents